- Home
- AVBP vs REX Comparison
AVBP vs REX Comparison
Compare AVBP & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- REX
- Stock Information
- Founded
- AVBP 2021
- REX 1980
- Country
- AVBP United States
- REX United States
- Employees
- AVBP N/A
- REX N/A
- Industry
- AVBP
- REX Major Chemicals
- Sector
- AVBP
- REX Industrials
- Exchange
- AVBP NYSE
- REX Nasdaq
- Market Cap
- AVBP 617.4M
- REX 644.0M
- IPO Year
- AVBP 2024
- REX N/A
- Fundamental
- Price
- AVBP $18.14
- REX $39.97
- Analyst Decision
- AVBP Strong Buy
- REX Strong Buy
- Analyst Count
- AVBP 6
- REX 1
- Target Price
- AVBP $39.00
- REX $50.00
- AVG Volume (30 Days)
- AVBP 271.0K
- REX 202.7K
- Earning Date
- AVBP 05-07-2025
- REX 05-21-2025
- Dividend Yield
- AVBP N/A
- REX N/A
- EPS Growth
- AVBP N/A
- REX N/A
- EPS
- AVBP N/A
- REX 3.30
- Revenue
- AVBP N/A
- REX $642,491,000.00
- Revenue This Year
- AVBP $63.13
- REX $3.27
- Revenue Next Year
- AVBP N/A
- REX $17.11
- P/E Ratio
- AVBP N/A
- REX $12.12
- Revenue Growth
- AVBP N/A
- REX N/A
- 52 Week Low
- AVBP $14.35
- REX $33.45
- 52 Week High
- AVBP $36.37
- REX $60.41
- Technical
- Relative Strength Index (RSI)
- AVBP 43.66
- REX 59.45
- Support Level
- AVBP $15.55
- REX $38.69
- Resistance Level
- AVBP $18.72
- REX $40.13
- Average True Range (ATR)
- AVBP 1.19
- REX 1.90
- MACD
- AVBP 0.34
- REX 0.42
- Stochastic Oscillator
- AVBP 76.95
- REX 91.32
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.